The Absolute Effect / Oncology Evidence
Germ Cell Tumour Trial Evidence
Clinical trial evidence for testicular germ cell tumours, emphasizing stage I management, surveillance, chemotherapy de-escalation and risk-adapted treatment.
Featured evidence
- German Testicular Cancer Study Group AH 01/94 — one cycle of BEP versus surgery in stage I non-seminoma.
- MRC TE05 — short-course BEP in high-risk stage I non-seminoma.
- MRC TE08 — reduced CT imaging during surveillance.
- MRC TE19 / EORTC 30982 — carboplatin versus radiotherapy in stage I seminoma.
- GETUG-13 — risk-adapted intensification in poor-prognosis metastatic disease.
- EORTC 30941 / MRC TE20 — three versus four cycles of BEP in good-prognosis metastatic germ cell tumours.